Digital Identity Solutions Industry is Led by North America

The digital identity solutions market revenue was USD 33,874.9 million in 2023, which will touch USD 117,416.1 million, with a 19.6% CAGR, by 2030.

To learn more about this report: https://bit.ly/3Hf4spI

The progression in this industry is because of the surging number of fraudulent activities and cybercrime in the banking and healthcare sectors. Also, there has been a significant advancement in ID wallet solutions, which give attackers more info to steal or attack.

Therefore, actions are being taken to incorporate blockchain, AI, and ML into digital identity solutions, to improve user security.

The biometric category, based on identity type, is leading the industry, with a 65% share, and it will remain leading in the coming years. This will be because of the significant security offered by the biometric parameters to users. 

Generally, passwords were employed extensively for identity verification, however, they are more likely to be shared, hacked, or forgotten.

The retail and e-commerce category, based on vertical, will propel at the fastest rate in the years to come. This is mainly because of the increasing count of cyber threats as well as the rising acceptance of online transactions.

North America is leading the industry, with approximately 40% share, and it will remain leading throughout this decade. This continent is home to numerous key companies, which strongly focus on innovation, to meet the surging need for advanced as well as highly protected digital identity solutions.

With the increasing incidence of cybercrimes & frauds, the digital identity solutions industry will grow continuously in the coming years.

Read More

Rising Acceptance of AR/VR Products Boosts Volumetric Video Industry

The volumetric video market was USD 2,377.4 million in 2023, which will touch USD 13,939.6 million, growing at a 28.8% compound annual growth rate, by 2030. 

The growth of this industry is because of the increasing rate of technological advancement, mounting use of AR/VR products, and rising expenses on the development of sports technologies.

Moreover, the arrival of 5G brings the advantages of low latency with high bandwidth and speed, allowing the incorporated provision of such video content. With this, the rising uses of this technology in holograms, gaming, brand experiences, training, and metaverse assist the industry expansion.

In 2023, North America was the largest contributor to the industry, with a 55% share, and it is likely to remain the largest in the years to come. This is because of the high pace of acceptance of developed technologies like VR, MR, and AR; the growing requirement for attractive signage and advertisements, and the existence of many companies.

APAC is likely to advance at the highest compound annual growth rate in the years to come. This is because of the large customer base for all sectors, the increasing standard of living of people with disposable salaries, quick urbanization, the growing need for enhanced sports-watching experiences, and the surging volume of specific image-guided surgical measures.

With the increase in the acceptance of AR or VR, the volumetric video industry will continue to progress in the years to come.

Read More

North America was the Leader of the Multiplex Assays Market

The multiplex assays market produced USD 3,918 million revenue in 2023, and it will power at a rate of 9% by the end of this decade, touching USD 7,103.5 million by 2030.

To learn more about this report: https://bit.ly/4aNVHAn

The main factor powering the industry is the growing incidence of chronic ailments and infectious diseases. Also, the growing requirement for effective analytical platforms in research and medical diagnostics, to decrease the costs for researchers, healthcare providers, and patients, is a robust contributor.

On the basis of product, the consumables category led the industry with a share, of 45%, in 2023. It was because of the increase in the count of diagnostic tests and surge in research actions by life sciences companies.

For example, in January 2023, Novo Nordisk, a pharma company, publicized a USD 6-million grant for Durham Technical Community College, for supporting the later’s life sciences program and set up a novel training center with area of 35,000 square feet.

The protein-based category led the multiplex assays market, with a 50%, share in 2023, due to the growing applications of these kinds of products in proteomics studies. Furthermore, protein-based assays are extensively used in research to recognize the protein concentration, electrophoresis, cell biology and other analytes.

The flow cytometry category led the industry in 2023, because of the numerous applications of this tech in the discovery and measurement of proteins and RNA and in the assessment of cell health.

For instance, Life Sciences Core Facilities, the Flow Cytometry Unit, Weizmann Institute of Science’s is making the use of imaging flow analyzers that combine the high-amount quantification of flow cytometry with microscopy and aid in the study of post-translational alterations and protein, protein interactions in different contexts.

North America led the industry with a share of 55%, in 2023, and it will power at a considerable rate, as a result of the increase in the research and development activities by biotech and pharma companies for the expansion of new drugs and diagnostic solutions. 

For example, in Jan 2023, PharmaEssentia Corporation publicized plans for a new PIRC in Greater Boston, Massachusetts. Likewise, in October 2022, Lineage Cell Therapeutics Inc. publicized the opening of a novel research and development facility in California and the development of its GMP-compliant capability in Israel. Lineage’s novel facility in California will extend its R&D competences in the U.S. and support the expansion of present and future allogeneic cell transplant programs.

It is because of the growing prevalence of chronic and infectious diseases all over the world, the demand for multiplex assays is on the rise. This trend will also continue in the years to come as well.

Read More

Software had a Considerable Share in the Patient Referral Management Software Industry

The size of the patient referral management software market was USD 9,598.3 million in 2023, and it will power at a rate of 17.9% by the end of this decade, to touch USD 30,221.2 million by 2030.

To learn more about this report: https://bit.ly/4aHv5kv

The increasing elderly populace across numerous nations, government initiatives to boost healthcare systems to accept IT solutions, and incessant tech expansions are some of the major reasons that can be credited for the growth of the industry.

Moreover, precision in scheduling actions, competence in data management, streamlining of everyday processes, and development in the access to medical amenities are some of the recompences of this kind of software that would let the industry to uphold momentum.

More than a few ailments are common in old age. An effective referral system can support in upholding the needed degree of communication and coordination amongst the numerous levels of the healthcare system, for example secondary-care hospitals, main-care or local hospitals, and tertiary-care facilities.

The patient referral management software market share of the cloud-based category will be the larger in the years to come. It can be credited to the rising recognition of cloud-based solutions because of their negligeable capital spending for data security, hardware setup, deterrence of the loss of info, and enhanced scalability of the storing capacity. Health records and further critical data can be managed and stored online more easily by using cloud-based solutions.

Eventually, cloud deployment offers improved flexibility and cost-efficiency as opposed to on-premises disposition. Applications, software, and tools can be effortlessly combined with the cloud system, and therefore, the requirement for cloud-based solutions will be on the rise in the future.

It is because of the growing elderly population all over the world, the requirement for patient referral management software is on the rise. This trend will continue to grow in the years to come as well.

Read More

Surging Aging Population Boosts Medical Exoskeleton Industry

The medical exoskeleton market was USD 485.8 million in 2023, which will increase to USD 6,336.8 million, powering at a 44.8% CAGR, by 2030.

This growth is because of the surging number of individuals with physical disabilities, the rising number of orthopedic surgeries, and the mounting elderly populace. For example, as per the WHO, 1 in 6 individuals globally, or around 1.3 billion individuals, experience substantial disability.

Furthermore, the mounting number of serious injuries, strokes, and road accidents is assisting the industry expansion. Around 1.3 million individuals die every year due to road traffic accidents, according to the WHO. Therefore, the rising acceptance of medical exoskeletons to heal injuries is further boosting this expansion.

In 2023, the hardware category, based on component, led the industry, with a 60% share, and it will propel at a 45.0% CAGR, during this decade. This can be because exoskeletons are produced with different pieces of hardware like sensors, actuators, control systems, and powered systems.

The powered category is the larger type, primarily owing to the new developments in them. For example, with investment from the National Institutes of Health, Stanford University has created an exoskeleton that rapidly adapts to users’ motions while they walk naturally.

Moreover, the passive category is a significant contributor to the industry. Passive exoskeletons are mainly accepted in low-income and developing nations, particularly by those who can’t buy the powered ones.

North America led the industry in 2023, with a 55% share, and it will further advance at a significant rate, in the years to come. This will be because of the mounting aging populace, rising government support for exoskeletons, and the high occurrence of neurological illnesses.

APAC is the fastest-growing region. This can be primarily ascribed to the increasing funding in healthcare, the growing patient pool requiring mobility support and rehabilitation, and the latest product approvals.

With the surge in the elderly populace across the globe, the medical exoskeleton industry will continue to progress in the years to come.

Read More

North America Is Dominating AI In Medical Diagnostics Industry

The value of the AI in medical diagnostics market stood at USD 1,297.6 million in 2023, and this number is projected to reach USD 5,541.7 million by 2030, advancing at a CAGR of 23.1% during the projection period.

To learn more about this report: https://bit.ly/3TiY08k

This is mainly because of the growing government steps for the acceptance of AI-based tech, the increasing use of AI solutions by radiotherapists to reduce workload, the obtainability of funds to start AI-based startups, the arrival of big data, and the rising cost of cross-market partnerships & collaborations.

The acceptance of big data is being influenced by the increasing digitalization and the growth of enhanced information systems in the medicinal market, producing huge and complex data at several stages of care delivery procedures.

Big data in the medicinal diagnostics area includes information generated from clickstream and social media interactions; readings from therapeutic instruments like billing records, ECG systems, sensors, X-rays, biometric data; and other healthcare claims, among other sources.

In 2023, software emerged as the largest component category in the industry, with approximately USD 0.5 billion. and it is also projected to hold its leading position during the projection period. This is mainly because of the rising need for AI solutions based on software in the medicinal diagnostics industry for providing precise results in a short span of time and the increasing count of IT firms providing the same.

The North American region dominates AI in the medical diagnostics industry, with a revenue share of 45% in 2023. This is mainly because of the high research and development investments, the rising acceptance of technically progressive solutions, and the existence of global players and their hard work to come up with pioneering medical diagnostics technologies, in the continent.

Increasing use of machine algorithms and IT software to imitate human analysis and understand complex medical data, increasing government initiatives to adopt AI technologies, and increasing use of AI solutions by radiologists to reduce workload are major drivers of the market for AI in medical diagnostics.

Read More

North America Is Dominating In-Situ Hybridization Industry

In 2023, the in-situ hybridization market amounted to USD 1,742.3 million and is set to grow at a compound annual growth rate of 12.8% between 2024 and 2030 reaching an estimated amount of USD 4,017.3 million by 2030.

This development of the market can be credited to the increasing acceptance of the in-situ hybridization (ISH) process for identifying numerous genetic illnesses and cancer, the rising pace of improvements in this method, and growing private and public funding for the research and development sector. Moreover, the rising demand for modified medicines is projected to fuel the industry growth.

There has been a distressing surge in cases of cancer worldwide in the past few years. This has caused a surge in the number of examined studies connected with this illness and those revolving around certain genomic irregularities, which are likely risk factors for numerous types of carcinomas.

In 2023, the FISH technology had a significant share, credited to the extensive variety of applications of this tech in diagnostics, like characterization with the aid of marker chromosomes, finding of numerical and structural chromosome flaws, finding of unusual and hereditary conditions, and drug abuse tracking.

In 2023, the North American region, generated the largest revenue share, of 55%, in the worldwide industry for in-situ hybridization solutions. The North American industry is projected to continue to uphold its dominating position during the projection period, mainly credited to the increasing count of autosomal diseases, cancer cases, genetic disorders, and also communicable conditions in the continent.

The U.S. is the key revenue generator in North America, mainly because of the strong government and private backing for the growth of new companion diagnostics methods.

Read More

North America is Dominating Behavioral Health Software Industry

In 2022, the global behavioral health software market was worth around USD 2,831 million, and it is projected to advance at a 16.10% CAGR from 2022 to 2030, hitting USD 9,346 million by 2030, according to P&S Intelligence.

To learn more about this report: https://bit.ly/3Vc98mf

This growth can be ascribed to the rising requirement for mental health software, the obtainability of government backing, and initiatives to boost the acceptance of EHRs in psychiatric hospitals. The nonstop requirement for solutions to advance mental health is the vital element fuelling the industry's expansion.

The services offered under the behavioral health umbrella comprise those for alcohol and drug misuse, mental health, anxiety, schizophrenia, post-traumatic stress disorder, and eating disorders. Over the years, mental syndromes have witnessed a stable growth in occurrence, thus leading to a hike in the demand for effective counseling and treatment.

The main factors for individuals to suffer from behavioral problems comprise chronic illnesses, traumatic lives because of problems in work and relations, and monetary issues. Approximately 20% of the world’s kids and teenagers have a psychiatric issue, with suicide the second-leading reason for demise among 15–29-year-olds. In battlefields and post-war situations, one in five individuals suffers from mental sickness.

In 2022, the software category held the larger market share, approximately 55%, and is also projected to be in the leading spot till 2030. This can be credited to the growing acceptance of technologically progressive solutions to manage the clinical, administrative, and financial features of psychiatric practices.

In 2022, North America held the largest revenue share in the behavioral health software market, at approximately 42%, and is also projected to maintain its dominance in the future as well. The U.S.’s huge share of the industry in the continent is credited to the increase in the count of individuals needing such services for liberty from mental disorders.

Hence, the nonstop requirement for solutions to advance mental health is the vital element fuelling the industry's expansion.

Read More

Growth of the Patient Engagement Solutions Market in North America

The patient engagement solutions market in North America is generated $3.9 billion in 2017 and is expected to witness a CAGR of 15.8% during the forecast period 2018–2023. Patient engagement refers to the process of establishing communication between patients and their healthcare providers online.

With smooth connectivity, the sharing of medical history, treatment schedule, medication prescriptions, and lab reports has become extremely easy. Patients are more concerned about their personal information and comfort today compared to the past, and therefore demand technologies that can consolidate all their medical information in one place and help them access and share it whenever and from wherever they want. This is why the patient engagement solutions market in North America is progressing.

To Learn More About this Report@ http://bit.ly/393TIY7

On segmenting by component, hardware, services, and software are the three resulting market categories, among which the software category accounted for the largest share (57.2%) in 2017. While this category will still lead the market during the forecast period, the services category will witness the fastest growth (18.1% CAGR). Similarly, the North American patient engagement solutions market can be segmented by delivery mode. Among the three categories under this segment, viz. web-based, on-premises, and cloud-based, the web-based category dominated the market in 2017 with 62.3% revenue contribution.

There is no doubt that elderly people need extensive care, as they are more prone to chronic diseases, such as cancer and diabetes. According to the American Cancer Society (ACS), around 1,688,780 new cases of cancer were diagnosed in the U.S. in 2017. Similarly, the Foundation for AIDS Research (amfAR) reported that in 2016, almost 1.1 million people in North America were suffering from AIDS. With the increasing number of elderly or even comparatively young people prone to such chronic diseases, who are demanding patient engagement solutions, the patient engagement solutions market in North America is predicted to advance in the future.

Thus, we see that owing to conducive government policies and increasing incidents of chronic diseases in the elderly, the North American patient engagement solutions market is predicted to witness steady progress.

Read More